In clinical study PIONEER-HF, the time-averaged reduction of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration was significantly greater in the SAC/VAL group than in the enalapril group. The gene discussed is NPPB; the disease is hydrops fetalis.